Investors in revance therapeutics, inc. should contact levi & korsinsky before march 4, 2025 to discuss your rights – rvnc

New york, jan. 22, 2025 (globe newswire) -- levi & korsinsky, llp notifies investors in revance therapeutics, inc. ("revance" or the "company") (nasdaq: rvnc) of a class action securities lawsuit.

RVNC Ratings Summary

RVNC Quant Ranking